These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37759476)

  • 1. NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms.
    Ganaiem M; Gildor ND; Shazman S; Karmon G; Ivashko-Pachima Y; Gozes I
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk.
    Ganaiem M; Karmon G; Ivashko-Pachima Y; Gozes I
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I
    Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
    Gozes I; Shazman S
    Eur J Neurosci; 2023 Jul; 58(2):2641-2652. PubMed ID: 36669790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.
    Gozes I
    Peptides; 2011 Feb; 32(2):428-31. PubMed ID: 21050875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.
    Karmon G; Sragovich S; Hacohen-Kleiman G; Ben-Horin-Hazak I; Kasparek P; Schuster B; Sedlacek R; Pasmanik-Chor M; Theotokis P; Touloumi O; Zoidou S; Huang L; Wu PY; Shi R; Kapitansky O; Lobyntseva A; Giladi E; Shapira G; Shomron N; Bereswill S; Heimesaat MM; Grigoriadis N; McKinney RA; Rubinstein M; Gozes I
    Biol Psychiatry; 2022 Jul; 92(1):81-95. PubMed ID: 34865853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
    Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I; Gozes I
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.
    Jouroukhin Y; Ostritsky R; Gozes I
    J Mol Neurosci; 2012 Nov; 48(3):597-602. PubMed ID: 22956189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    Ivashko-Pachima Y; Maor-Nof M; Gozes I
    PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.
    Gozes I; Ivashko-Pachima Y
    Front Aging Neurosci; 2015; 7():205. PubMed ID: 26578950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
    Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
    J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ADNP Syndrome and CP201 (NAP) Potential and Hope.
    Gozes I
    Front Neurol; 2020; 11():608444. PubMed ID: 33329371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAP Protects against Tau Hyperphosphorylation Through GSK3.
    Ivashko-Pachima Y; Gozes I
    Curr Pharm Des; 2018; 24(33):3868-3877. PubMed ID: 30417779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau, ADNP, and sex.
    Gozes I
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):16-23. PubMed ID: 37572043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
    Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
    Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
    Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
    Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.